glp-1 intracranial hypertension Recurrent Idiopathic Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema A retrospective cohort study assessed

SKU: 76052585007

Pay in 4 interest-free payments of $6.32 Learn more

Live Spec

A retrospective cohort study assessed outcomes among patients with idiopathic intracranial hypertension who received glucagon like peptide 1 receptor agonists. Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates PMC JAMA Most viewed this week from JAMA Neurology: GLP 1 RA therapy may offer an alternative management strategy for idiopathic intracranial hypertension. https: ja.ma 4lEb4AD Facebook glp 1 for intracranial hypertension Association between GLP 1 receptor agonist use and neurosurgical intervention in patients with idiopathic intracranial hypertension and obesity: a propensity matched, multi institutional, cohort study Idiopathic Intracranial Hypertension After Abrupt Cessation of Medication: A Case Report of Abrupt Glucagon Like Peptide 1 (GLP 1) Receptor Agonist Cessation and Review of the Literature PMC

Store: paygroup.it · Domain: paygroup.it